| The Nuclear Regulatory Commission
is making available final guidance for obtaining a license, under newly revised
regulations, to use radioactive materials in medical diagnosis, treatment and
research.
The document, “Consolidated Guidance About Materials Licenses: Program-Specific
Guidance About Medical Use Licenses” (NUREG-1556, Volume 9), is a result
of significant staff effort and public review, including several public workshops.
A summary of public comments on the guidance and NRC responses will be published
as a separate document, Appendix BB to NUREG-1556, Volume 9. The comments and responses will also be available in electronic
form on CD-rom.
Revised regulations, effective October 24, focus on medical procedures that
pose higher risks to workers, patients, and the public from a radiation safety
aspect. The guidelines for these regulations provide a single, comprehensive
source of information for use by applicants, licensees and NRC staff and consolidate
guidance found in 15 other NRC documents.
A copy of NUREG-1556, Volume 9 and Appendix BB - on paper or CD-rom - may
be requested in writing to the U.S. Nuclear Regulatory Commission, ATTN: Mrs.
Carrie Brown, Mail Stop T 9-C24, Washington, DC 20555-0001; by email at CXB@nrc.gov;
or by telephone at 301-415-8092. Single copies of the documents are also available
for inspection and/or copying for a fee in the NRC Public Document Room, located
at 11555 Rockville Pike, Rockville, Maryland. These documents will also be
available on the NRC’s web site at http://www.nrc.gov/materials/miau/miau-reg-initiatives/by-product.html.
For additional information about the guidance, contact Roger W. Broseus,
Rulemaking and Guidance Branch, Mail Stop T 9-C24, Division of Industrial
and Medical Nuclear Safety, Office of Nuclear Material Safety and Safeguards,
U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001; by telephone
at 301-415-7608; or by e-mail at RWB@nrc.gov.
|
